KIT and systemic mastocytosis: The role of c-Kit in cancer is mainly proto-oncogenic, and it has been reported that 78% of all gastrointestinal stromal tumors (GISTs) and over 90% of systemic mastocytosis myeloid neoplasms carry c-Kit mutations [46,47].